Target intelligence / Profile preview

Dynein axonemal heavy chain 17 (DNAH17)

Target
DNAH17
Molecular classification
Motor protein, Microtubule-associated protein, Axonemal dynein heavy chain, Other
01

Overview

Dynein axonemal heavy chain 17 (DNAH17) is a force-generating component of the outer dynein arms (ODAs) in the sperm flagellum, part of the axonemal dynein motor complex essential for microtubule-based motility. DNAH17 hydrolyzes ATP to produce force towards the minus ends of microtubules and plays a key role in sperm flagellar assembly and effective motility. Mutations in DNAH17 selectively disrupt sperm ODA function, resulting in isolated nonsyndromic male infertility (e.g., spermatogenic failure 39, asthenozoospermia, or multiple morphological abnormalities of the sperm flagellum), without affecting ciliary function in the respiratory tract[1][2][3]. DNAH17 is primarily relevant as a genetic cause and molecular marker for these infertility syndromes, not as a direct therapeutic target[1][3].

Other names
Dynein axonemal heavy chain 17DNAH17DNAHL1DNEL2FLJ40457Axonemal beta dynein heavy chain 17Axonemal dynein heavy chain-like protein 1Ciliary dynein heavy chain 17Ciliary dynein heavy chain-like protein 1Dynein axonemal light chain 2SPGF39
02

Biological functions

Force generation for microtubule-based motilitySperm flagellar assembly and beatingSperm motility
03

Disease associations

Male infertility (e.g., spermatogenic failure 39)Sperm motility disorder (asthenozoospermia, multiple morphological abnormalities of the sperm flagellum)Other
04

Safety considerations

Mutations may cause isolated male infertility; no evidence for systemic adverse effects or use as a therapeutic target
05

Biomarkers

Mutations in DNAH17 as genetic biomarkers for male infertility with specific sperm defects

Beyond the preview

Go deeper on Dynein axonemal heavy chain 17 (DNAH17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynein axonemal heavy chain 17 (DNAH17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call